for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

AbbVie clinches Shire deal

AbbVie succeeds in its pursuit of Shire with a $53 billion deal which will give the U.S. pharma giant access to Shire's premium medicines for rare diseases, and, potentially, slash its tax bills. David Pollard reports.

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up